Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2008
Retinoic acid-gated sequence-specific translational control by RARalphaMichael M Poon, Lu ChenPlos One|September 22, 2011
Functional characterization of the dendritically localized mRNA neuronatin in hippocampal neuronsElaine L Oyang, Bonnie C Davidson, Winfong Lee, et al.Neuron|October 30, 2008
Synaptic signaling by all-trans retinoic acid in homeostatic synaptic plasticityJason Aoto, Christine I Nam, Michael M Poon, et al.Proceedings of the National Academy of Sciences of the United States of America|October 9, 2008
Retinoic acid regulates RARalpha-mediated control of translation in dendritic RNA granules during homeostatic synaptic plasticityBita Maghsoodi, Michael M Poon, Christine I Nam, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 22, 2006
Identification of process-localized mRNAs from cultured rodent hippocampal neuronsMichael M Poon, Sang-Hyun Choi, Christina A M Jamieson, et al.ACS Medicinal Chemistry Letters|January 25, 2021
Discovery of PIPE-359, a Brain-Penetrant, Selective M1 Receptor Antagonist with Robust Efficacy in Murine MOG-EAEThomas O Schrader, Yifeng Xiong, Ariana O Lorenzana, et al.Journal of Medicinal Chemistry|June 29, 2026
Discovery of PIPE-791, A Potent and Brain-Penetrant Lysophosphatidic Acid Receptor 1 Antagonist with Slow Tight Binding Characteristics for the Treatment of Neuroinflammatory DisordersAustin Chen, Christopher Baccei, Jill Baccei, et al.ACS Chemical Neuroscience|January 24, 2024
Identification and In Vivo Evaluation of Myelination Agent PIPE-3297, a Selective Kappa Opioid Receptor Agonist Devoid of β-Arrestin-2 Recruitment EfficacyThomas O Schrader, Kym I Lorrain, Didier Bagnol, et al.Proceedings of the National Academy of Sciences of the United States of America|July 31, 2024
Targeting the muscarinic M1 receptor with a selective, brain-penetrant antagonist to promote remyelination in multiple sclerosisMichael M Poon, Kym I Lorrain, Karin J Stebbins, et al.Scientific Reports|May 8, 2024
Discovery of a brain penetrant small molecule antagonist targeting LPA1 receptors to reduce neuroinflammation and promote remyelination in multiple sclerosisMichael M Poon, Kym I Lorrain, Karin J Stebbins, et al.Pageof 1